Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Pheno Therapeutics has gained clinical trial authorisation (CTA) from the UK's MHRA for its small molecule therapeutic, ...

Some people with MS may have only mild symptoms ... in the Annals of Clinical and Translational Neurology under the title “Subclinical imaging activity in multiple sclerosis patients during ...

Relapsing-remitting multiple sclerosis ... until symptoms slowly improve, with or without treatment. Between RRMS relapses, you will experience periods of remission with no clinical evidence ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received ...

Multiple sclerosis (MS) is a neurodegenerative disease that causes demyelination of the CNS. MS can cause a wide variety of neuro-ophthalmic manifestations and is also associated in some cases ...

with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate and nourish axons and nerve fibers in the ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Formerly believed to predominantly affect Caucasians, new research indicates that MS actually may hit Blacks the hardest.